This is a routine board appointment with no trading implications. Monitor for any future committee assignments or healthcare-related strategic initiatives, but no immediate action warranted.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 13 $56.38entry
- T+1 · 6mo ago 0.00%α +0.00% · $56.38
- T+5 · 6mo ago −4.10%α −2.94% · $54.07
- T+20 · 5mo ago −2.70%α −2.08% · $54.86
- T+60 · 3mo ago −18.25%α −22.69% · $46.09
Price Chart
How similar events traded
Executive Summary
Oracle elected Dr. Tomislav Mihaljevic, CEO of Cleveland Clinic, to its Board of Directors, expanding the board to 13 members. This is a routine governance appointment with no financial impact, as Dr. Mihaljevic will receive standard non-employee director compensation.
Key Facts
- Tomislav Mihaljevic elected to Oracle's Board of Directors effective May 6, 2026
- Board size increased to 13 members
- Dr. Mihaljevic is CEO and President of Cleveland Clinic
- He will receive standard RSUs and cash compensation for non-employee directors
- No related party transactions or family relationships with Oracle executives
- Press release issued May 12, 2026
Financial Impact
No material financial impact, standard director compensation only
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-219708 |
| Document: d76569dex991.htm | 0001193125-26-219708 |
| Document: 0001193125-26-219708-index-headers.html | 0001193125-26-219708 |
| Document: 0001193125-26-219708-index.html | 0001193125-26-219708 |
| Document: 0001193125-26-219708.txt | 0001193125-26-219708 |
Track record
23 reports on ORCL
4 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +18.86% at T+20 after the Apr 6, 2026 report. 7 of 10 went positive at some point.
Filters
- Nov 4, 202612d ago 8-K Bearish 5/10 Entry $115.16 to $127.11 Now $125.35 −8.85% ▼ −10.38% −7.09% vs SPY
- Nov 3, 202613d ago 424B5 Bearish 5/10 Entry $123.73 to $128.38 Now $125.35 −1.31% ▼ −3.76% −4.67% vs SPY
- Nov 2, 202613d ago Press Release Bearish 6/10 Entry $126.19 to $117.98 Now $125.35 +0.67% ▲ +6.51% +5.92% vs SPY
- Nov 2, 202614d ago 424B5 Bearish 5/10 Entry $119.22 to $119.79 Now $125.35 −5.14% ▼ −0.48% −0.40% vs SPY
- Nov 2, 202614d ago S-3ASR Neutral 2/10 Entry $119.22 to $119.79 Now $125.35 +5.14% ▲ +0.48% +0.40% vs SPY
- Oct 28, 202619d ago 8-K Neutral 5/10 Entry $144.54 to $123.73 Now $125.35 −13.28% ▼ −14.40% −13.69% vs SPY
- Oct 22, 202625d ago Institutional Cluster Mixed 3/10 Entry $126.16 to $130.67 Now $125.35 −0.64% ▲ +3.57% +4.13% vs SPY
- Oct 1, 20266w ago Insider Cluster Mixed 5/10 Entry $142.30 to $141.40 Now $125.35 −11.91% ▼ −0.63% −1.79% vs SPY
- Sep 25, 20267w ago DEFA14A Neutral 2/10 Entry $132.60 to $142.48 Now $125.35 −5.47% ▲ +7.45% +6.25% vs SPY
- Sep 25, 20267w ago DEF 14A Neutral 3/10 Entry $132.60 to $142.48 Now $125.35 −5.47% ▲ +7.45% +6.25% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers